Pharmaceutical management consulting company Cutting Image Information in its latest study has found that 61% of the surveyed companies like Amgen, Pfizer, Novartis, Johnson & Johnson and AstraZeneca outsource some part of their material development activities, customer services, market research and other communication program. Its strange that pharmaceutical companies which actually deal with life saving drugs deploy more aggressive marketing strategy than lot of other industries. Some companies are spending world of monies to retain the existing patents, and thus outsourcing lot of related activities. Add to that domains like patient confidentiality issues which are being outsourced “as doctors and patients are more comfortable with outside vendors handling patient records rather than pharmaceutical companies.”
Comment Preview